COMPASS Pathways (CMPS) EBITDA (2021 - 2026)

COMPASS Pathways has disclosed EBITDA across 6 years of filings, most recently posting $91.2 million for Q1 2026.

• In Q1 2026, EBITDA rose 607.18% year-over-year to $91.2 million; the TTM figure through Mar 2026 stood at -$177.3 million (down 29.26% YoY), while the FY2025 annual figure was -$286.5 million, down 85.54% from the prior year.
• EBITDA grew to $91.2 million in Q1 2026, from -$93.5 million in the prior quarter.
• Over the last five years, EBITDA for CMPS reached as high as $91.2 million in Q1 2026 and fell as low as -$138.3 million in Q3 2025.
• The 5-year median for EBITDA is -$34.1 million (2023), against an average of -$34.4 million.
• Annual changes were most pronounced in 2025 — EBITDA sank 262.45% — and 2026, when it surged 607.18%.
• A 5-year view of EBITDA shows it stood at -$17.2 million in 2022, then tumbled by 86.54% to -$32.0 million in 2023, then plunged by 34.36% to -$43.0 million in 2024, then slumped by 117.48% to -$93.5 million in 2025, then jumped by 197.56% to $91.2 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $91.2 million, -$93.5 million, and -$138.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.